Is the impact of childhood influenza vaccination less than expected: A transmission modelling study

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Weidemann, Felix ^a   Remschmidt, Cornelius ^a   Buda, Silke ^a   Buchholz, Udo ^a   Ultsch, Bernhard ^a   Wichmann, Ole ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Bayesian inference; Childhood vaccination; Influenza; NNV; Transmission model

Indexed keywords

INFLUENZA VACCINE;

AGE; AGED; ARTICLE; BAYES THEOREM; CHILD; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GERMANY; HUMAN; INFLUENZA VACCINATION; MALE; MATHEMATICAL MODEL; PHENOMENOLOGY; PREDICTION; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SEASONAL INFLUENZA; SEASONAL VARIATION; VIRUS STRAIN; VIRUS TRANSMISSION; ACUTE DISEASE; ADULT; BIOLOGICAL MODEL; HEALTH IMPACT ASSESSMENT; IMMUNOLOGY; INCIDENCE; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; SEASON; TRANSMISSION;

ACUTE DISEASE; ADULT; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HEALTH IMPACT ASSESSMENT; HUMANS; INCIDENCE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SEASONS;

EID: 85018493433     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2344-6     Document Type: Article

References (55)

1. Neuzil KM, Hohlbein C, Zhu Y. Illness among schoolchildren during influenza season: Effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med. 2002;156(10):986-91.
2. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect. 1993;110(1):145-60.
3. WHO. Influenza vaccines-WHO position paper. Wkly Epidemiol Rec. 2005;33:279-87.
4. ECDC. ECDC Vaccination schedule. [cited 2016; Available from: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx.
5. Michiels B, et al. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011;29(49):9159-70.
6. Jefferson, T., et al., Vaccines for preventing influenza in healthy adults, in Cochrane Database Syst Rev. 2010.
7. Reichert TA, et al. The Japanese Experience with Vaccinating Schoolchildren against Influenza. N Engl J Med. 2001;344(12):889-96.
8. Grohskopf LA, et al. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep. 2015;64(30):818-25.
9. Pebody, R.G., et al., Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15. Euro Surveill, 2015. 20(39).
10. Loeb M, et al. Effect of influenza vaccination of children on infection rates in hutterite communities: A randomized trial. JAMA. 2010;303(10):943-50.
11. Spier R, et al. 3rd Vaccine Global Congress, Singapore 2009. Assessing Herd Immunity in the Elderly Following the Vaccination of School Children with Live Attenuated Trivalent Influenza Vaccine (LAIV): A County-Level Analysis. Proc Vaccinol. 2010;2(1):92-100.
12. Keipp Talbot H, et al. Influenza in Older Adults: Impact of Vaccination of School Children. Vaccine. 2009;27(13):1923-7.
13. Rhorer J, et al. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Vaccine. 2009;27(7):1101-10.
14. Flannery B. LAIV vs IIV effectiveness: Summary of evidence since 2009. In: Presented at: Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) Meeting; 2016 Jun 22-23; Atlanta, GA; 2016.
15. Centers for Disease Control and Prevention. ACIP votes down use of LAIV for 2016-2017 flu season. 2016.
16. Baguelin M, et al. Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study. PLoS Med. 2013;10(10):e1001527.
17. Vynnycky E, et al. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine. 2008;26(41):5321-30.
18. Rose MA, et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis. 2014;14:40-40.
19. Meeyai A, et al. Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis. PLoS Med. 2015;12(5):e1001829.
20. An der Heiden M, et al. Estimates of Excess Medically Attended Acute Respiratory Infections in Periods of Seasonal and Pandemic Influenza in Germany from 2001/02 to 2010/11. PLoS One. 2013;8(7):e64593.
21. Buda S, et al. Bericht zur in Deutschland Saison 2013/14. Berlin: Robert Koch-Institut; 2014.
22. Buchholz, U., A. Grüber, and B. Schweiger. Abschlussbericht der Influenzasaison. Robert Koch-Institut
23. STIKO. Statement of the German Standing Committee on Vaccination at the RKI: Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute. Epidemiol Bull. 2015;34:327-62.
24. Rieck T, et al. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother. 2014;10(2):476-84.
25. Jefferson, T., et al., Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev, 2010 (7).
26. Jefferson, T., et al., Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev, 2008(2).
27. Kissling, E., et al., Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014, 19(6).
28. Kissling E, et al. I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe. PLoS One. 2011;6(11):e27622.
29. Kissling, E., et al., "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill, 2009. 14(44).
30. Kissling, E., et al., Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 18(5).
31. Valenciano M, et al. Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009-2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study. PLoS Med. 2011;8(1):e1000388.
32. Valenciano M, et al. The European I-MOVE Multicentre 2013-2014. Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015;33(24):2813-22.
33. Langley JM, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis. 2013;208(4):544-53.
34. Tricco AC, et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013;11(1):1-19.
35. Eichner M, et al. 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis. 2014;14:365-365.
36. Goeyvaerts N, et al. Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. Epidemics. 2015;13:1-9.
37. Pitman RJ, White LJ, Sculpher M. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine. 2012;30(6):1208-24.
38. Ultsch B, et al. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics. 2016;34:227-44.
39. Gelman A, Hill J. Data analysis using regression and multilevel/hierarchical models. Cambridge: Cambridge University Press; 2006.
40. Finkenstädt BF, Grenfell BT. Time series modelling of childhood diseases: a dynamical systems approach. J R Stat Soc: Ser C: Appl Stat. 2000;49(2):187-205.
41. McCallum H, Barlow N, Hone J. How should pathogen transmission be modelled? Trends Ecol Evol. 2001;16(6):295-300.
42. Chowell G, et al. Characterizing the reproduction number of epidemics with early subexponential growth dynamics. J R Soc Interface. 2016;13
43. Kong, L., et al., Modeling Heterogeneity in Direct Infectious Disease Transmission in a Compartmental Model. Int J Environ Res Public Health, 2016. 13(3).
44. Mossong J, et al. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLoS Med. 2008;5(3):e74.
45. Goeyvaerts N, et al. Estimating Infectious Disease Parameters from Data on Social Contacts and Serological Status. J Royal Stat Soc Ser C Appl Stat. 2010;59(2):255-77.
46. Hermes J, et al. Lack of evidence for pre-symptomatic transmission of pandemic influenza virus A(H1N1) 2009 in an outbreak among teenagers; Germany, 2009. Influenza Other Respir Viruses. 2011;5(6):e499-503.
47. Eames K, et al. The impact of illness and the impact of school closure on social contact patterns. Health Technol Assess. 2010:14(34).
48. Van Kerckhove K, et al. The Impact of Illness on Social Networks: Implications for Transmission and Control of Influenza. Am J Epidemiol. 2013;178(11):1655-62.
49. Carrat F, et al. Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies. Am J Epidemiol. 2008;167(7):775-85.
50. Weidemann F, et al. Modelling the epidemiological impact of rotavirus vaccination in Germany - A Bayesian approach. Vaccine. 2014;32(40):5250-7.
51. Kass RE, Raftery AE. Bayes Factors. J Am Stat Assoc. 1995;90(430):773-95.
52. Hardelid, P., et al., Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A H1N1 2009. Health Technol Assess, 2011. 14(55).
53. Dudareva S, et al. Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic Period. PLoS One. 2011;6(6):e21340.
54. Basta NE, et al. Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States. Am J Epidemiol. 2009;170(6):679-86.
55. Bayer, C., et al., Internet-based syndromic monitoring of acute respiratory illness in the general population of Germany, weeks 35/2011 to 34/2012. Euro Surveill., 2014 19(4).